LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada (NCT07143110)
🩺 Plain-English Summary (8th-Grade Level)
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (3 items) and avoid the listed exclusions (5 items).
Location: Research Site — Calgary, Alberta
Age range: 18 Years to 130 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.
- Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.
- Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).
- Non-Ontario or non-Alberta resident on diagnosis date.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (2 Sites)
- Research Site — Calgary, Alberta
- Research Site — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (877) 240-9479
Email: information.center@astrazeneca.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Neoplasms
- Specimen Banking From Patients With Lung Cancer — Aurora, Colorado
- TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics — New Brunswick, New Jersey
- TELESCOPE- TELEhealth Shared Decision-making COaching — New Brunswick, New Jersey
- A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer — Jacksonville, Florida
- Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations — Gainesville, Florida
Explore by condition: All Lung Neoplasms clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.